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Membrane activity upregulates brain derived neurotrophic factor (BDNF) expression to coordinately support neuronal survival in many
systems. In parasympathetic ciliary ganglion (CG) neurons, activity mimicked by KCl depolarization provides nearly full trophic support. While
BDNF has been considered unable to influence CG neuronal survival, we now document its expression during CG development and show that low
concentrations do support survival via high-affinity TrkB receptors. Furthermore, a contribution of BDNF to activity-induced trophic support was
demonstrated by showing that KCl depolarization increased BDNF mRNA and protein in, and release of BDNF from, CG neuron cultures.
Application of anti-BDNF blocking antibody or mitogen activated protein kinase (MAPK) kinase inhibitor, attenuated depolarization-supported
survival, implicating canonical BDNF/TrkB signaling. Ca2+-Calmodulin kinase II (CaMKII) was also required since its inhibition combined with
anti-BDNF or MAPK kinase inhibitor abolished or greatly reduced the trophic effects of depolarization. Membrane activity may thus support CG
neuronal survival both by stimulating release of BDNF that binds high-affinity TrkB receptors to activate MAPK and by recruiting CaMKII. This
mechanism could have relevance late in development in vivo as ganglionic transmission and the effectiveness of BDNF over other growth factors
both increase.
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Neuronal survival involves the integration of signals pro-
duced by membrane electrical activity and by trophic
molecules from target, autocrine, and input sources. Activity
is crucial since silencing neurons reduces survival (Catsicas et
al., 1992; Furber et al., 1987; Galli-Resta et al., 1993; Lipton,
1986; Meriney et al., 1987) and since KCl depolarization can
support survival without added neurotrophic factors (Gallo et
al., 1987; Scott and Fisher, 1970). Ca2+ influx through
voltage-dependent Ca2+ channels (VDCCs) provides a critical
messenger for depolarization-induced survival (Franklin et al.,⁎ Corresponding author. Fax: +1 419 383 3008.
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downstream signaling effectors such as mitogen activated
protein kinase (MAPK) and Ca2+/calmodulin-dependent
protein kinase II (CaMKII) (Borodinsky et al., 2002; Farns-
worth et al., 1995; Hack et al., 1993; Hansen et al., 2001;
Hanson and Schulman, 1992; Rosen et al., 1994). In
conjunction with activity, protein growth factors, including
neurotrophins (NTs, i.e. nerve growth factor, NGF; brain derived
neurotrophic factor, BDNF; and neurotrophin-3, NT3), ciliary
neurotrophic factor (CNTF), and glial cell line derived neu-
rotrophic factor (GDNF) promote neuronal survival through
their high-affinity receptors (Trks, CNTFα/gp130/LIFR, and
GFRα1/Ret for NTs, CNTF, and GDNF, respectively) (Huang
and Reichardt, 2001; Segal, 2003). NTs, as well as GDNF,
promote neuronal survival through MAPK and PI3-K/Akt
signaling pathways (Airaksinen and Saarma, 2002; Bonni et al.,
1999; Datta et al., 1997; Yao and Cooper, 1995), while CNTF
promotes neuronal survival through activation of JAK/STAT
signaling (Bäckström et al., 1996; Segal and Greenberg, 1996).
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identifying requirements for parasympathetic neuron survival.
Normally, 50% of CG neurons die between E8 and E14 in vivo
(Landmesser and Pilar, 1974b). Eye removal prior to
innervation increases neuronal death, indicating that develop-
mental interactions with peripheral intraocular muscle targets
are necessary for survival (Landmesser and Pilar, 1974a, 1978;
Wright, 1981). In cell culture, nearly all CG neurons can
survive in media supplemented with neurotrophic factors, such
as CNTF (or its avian orthologue, growth promoting activity,
GPA), GDNF, or with elevated KCl concentrations (Buj-Bello
et al., 1995; Eckenstein et al., 1990; Leung et al., 1992; Nishi
and Berg, 1981; Pugh and Margiotta, 2000). While CNTF,
GPA, and GDNF are expressed in eye tissues (Barbin et al.,
1984; Buj-Bello et al., 1995; Hashino et al., 2001; Leung et al.,
1992), they are unlikely to support full CG neuronal survival
throughout development in vivo. First, although GPA receptors
(GPARα) mediating the effects of GPA and CNTF are present
throughout CG development (Heller et al., 1995), the ability of
CNTF to promote survival is substantially reduced for neurons
at stages later than E12 (Buj-Bello et al., 1995). Similarly,
GDNF potency and efficacy drop significantly for neurons
after E10, and expression of GDNF and its high affinity
receptor, GFRα1/Ret, declines in parallel well before the end
of CG neuron cell death at E14 (Buj-Bello et al., 1995;
Hashino et al., 2001). These findings suggest that neurotrophic
factors other than CNTF, GPA, or GDNF may protect CG
neurons during and after the period of programmed ganglionic
cell death in vivo.
Despite previous reports discounting a relevance for NT
signaling in CG neurons (Dechant et al., 1993; Hallbook et al.,
1995; Lindsay et al., 1985; Rohrer and Sommer, 1983), we
recently found that BDNF is present in the CG and that the
neurons express high-affinity BDNF (TrkB) receptors (Zhou et
al., 2004). Importantly, the TrkB receptors are functional in that
BDNF application triggers the canonical MAPK-dependent
signaling pathway in CG neurons, activating the transcription
factor CREB (Finkbeiner et al., 1997) and upregulating
nicotinic receptor expression and synaptic function (Zhou et
al., 2004). We now show that BDNF also supports long-term
survival of E8 CG neurons in culture when applied at
sufficiently low concentration to preferentially activate high-
affinity TrkB receptors. In other systems, depolarization rapidly
stimulates NT release and increases both NT synthesis
(Balkowiec and Katz, 2000; Castren et al., 1993; Zafra et al.,
1990) and expression levels of catalytically active Trks
(Kingsbury et al., 2003; Meyer-Franke et al., 1998). In cortical
and spiral ganglion neurons, the increased synthesis and release
of BDNF following chronic KCl depolarization and VDCC
activation indicate that activity enhances neuronal survival,
possibly by autocrine regulation of BDNF expression (Ghosh et
al., 1994; Hansen et al., 2001). Other studies indicate that
depolarization and NTs converge on the same MAPK and PI3-
K/Akt pathways to regulate neuron survival (Vaillant et al.,
1999). Together with the developmental appearance of
endogenous BDNF in the CG and the ability of exogenous
BDNF to support the survival of CG neurons, these considera-tions suggest a causal relationship between depolarization and
BDNF expression/release that could provide coordinated
trophic support to the neurons. In testing this hypothesis, we
found that chronic KCl depolarization dramatically increased
both BDNF mRNA and protein levels in CG cultures and that
depolarization-induced survival utilized both TrkB-dependent
(MAPK-mediated) and -independent (CaMKII-mediated) sig-
naling effectors. Taken together, our results indicate that
activity-regulated expression and release of endogenous
BDNF may participate with BDNF-independent processes in
promoting CG neuronal survival in vivo. Since BDNF also
supported long-term survival of mature (E14) CG neurons, the
coordinated survival support provided by activity and BDNF
may be particularly relevant at later stages of embryogenesis
(zE14) when synaptic transmission is reliable and the efficacies




CG neuron cultures were prepared under sterile conditions as previously
described (Chen et al., 2001; Pugh and Margiotta, 2000; Zhou et al., 2004).
Briefly, CG were dissected from embryonic day 8 (E8) chicken embryos,
digested with trypsin (0.025%, 15 min), and dissociated by mechanical
trituration. Dissociated neurons were plated at 2 ganglion equivalents per 12 mm
diameter glass coverslip (in 15 mm diameter multiwell plates) or 35-mm-
diameter polystyrene tissue culture dish; both surfaces were precoated with
poly-DL-ornithine and laminin (Chen et al., 2001; Pugh and Margiotta, 2000).
The basal culture medium consisted of minimum essential medium containing
100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM glutamine, and 10% heat
inactivated horse serum (MEMhs; all components from Invitrogen, Rockville,
MD). Depending on the experiment, MEMhs was supplemented with one or
more of the following: KCl (10 or 20 mM; final KCl concentration 15 or 25
mM), BDNF (5 or 50 ng/ml), anti-BDNF mAb (10 μg/ml, Clone 35928.11,
#GF35L, EMD Biosciences, San Diego, CA), PD98059 (7 μM, EMD
Biosciences), KN-93 (10 μM, EMD Biosciences), or embryonic chicken eye
extract (3% v/v). MEMhs containing 3% eye target tissue extract (MEMhs/eye) or
25 mM KCl was previously shown to support 100% and 70–100% survival of
CG neurons for at least 7 days in culture (Nishi and Berg, 1981). In all cases,
neurons were maintained at 37°C in 95% air and 5% CO2 for 4–7 days and
received fresh culture medium every 2–3 days (Nishi and Berg, 1981).
Survival assay
Neuronal survival was determined by established morphological criteria,
with CG neurons scoring as alive if they displayed large phase-bright somata
that extended processes 2–3 h after plating (Pugh and Margiotta, 2000). For
each growth condition, 9–12 fields from 2 to 3 wells were evaluated at 200×
magnification using an inverted phase-contrast microscope (Axiovert 10, Zeiss,
Thornwood, NY) and the average number of neurons per field per coverslip
determined. Neuron counts were repeated on D1, 2, 4, and sometimes D7 after
plating, and survival expressed as percent of the initial number of neurons
present per field per coverslip 2–3 h after plating (D0).
Real-time RT-PCR
Changes in BDNF mRNA levels induced by depolarization were measured
using RT-based real-time PCR. cDNA samples corresponding to 25–50 ng of
input RNA were combined with Taqman universal PCR master mix (Roche,
Branchburg, NJ), forward (F) and reverse (R) primers (0.4 μM), and Taqman
probe (0.1 μM) [with 6-FAM (carboxyfluorescein, reporter dye) and TAMRA
(tetramethylrhodamine, quencher dye) inserted at 5′ and 3′ ends, respectively].
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Probe C325TCGAGGAGTACAAAAACTACCTGGATGCTGC356GAPDH (Stone et al., 1985)
F C1795CGTCCTCTCTGGCAAAGTC1814
R A2374ACATACTCAGCACCTGCATCTG2352
Probe A2211TCAATGGGCACGCCATCACTATCTTCC2228Twenty-five microliter PCRs were performed in triplicate using a GeneAmp
5700 sequence detection system (Applied Biosystems). This system allows the
increase in PCR product to be monitored directly based on the threshold number
of cycles (C) required to produce a detectable change in fluorescence (ΔF)
resulting from the release of probe. Relative levels of BDNF (RB) in control
and KCl-treated cultures were calculated from the difference in C values
(ΔC = CControl − CKCl) for BDNF amplification (ΔCB) compared with those
for the housekeeping gene GAPDH (ΔCG) using
RB ¼ ðEDCBB Þ=ðEDCGG Þ ð1Þ
In Eq. (1), EB and EG are the BDNF and GAPDH cDNA amplification
efficiencies determined in separate studies from the slope of C versus input log
cDNA dilution where E = 10−1/slope (Zhou et al., 2004). EB and EG values
obtained in this manner were both 1.8.
ELISA
The presence of BDNF in ciliary ganglion and neuron culture extracts and in
culture media was assessed using a commercial BDNF sandwich ELISA kit
(Chemikine #CYT306, Chemicon, Temecula, CA) that recognizes human and
rat BDNF and has no significant cross-reactivity with NGF, NT4/5, or NT3, as
previously described (Zhou et al., 2004). Levels of BDNF-like protein were
quantified within the linear range of the assay (7.8 to 500 pg/ml) using
recombinant human BDNF as standard.
Testing anti-human BDNF antibodies
Commercial BDNF antibodies (cited above), both generated against human
BDNF, were used to probe for chicken BDNF because a BLAST search of
18,141 chicken protein sequences indicates that mature human and chicken
BDNF share 94% identity (112/119 amino acids) (Altschul et al., 1997). The
ability of these anti-human BDNF antibodies to cross-react with chicken BDNF
was verified by immunodepletion and immunoprecipitation of E14 chicken
brain extracts followed by Western blot analysis. Brains were homogenized (at
50 mg tissue/ml buffer) on ice in 50 mMTris (pH 7.4) containing 0.5% Triton X-
100 and protease inhibitor cocktail (1:200, #P8340, Sigma-Aldrich, St. Louis,
MO) using a 100 μl glass tissue grinder. Brain extracts were solubilized in
homogenization buffer for 1 h at 4°C, and insoluble material removed by
centrifugation (20,000 × g). Equal amounts of extract supernatant (containing
700 μg protein/ml) were incubated either alone or with the anti-BDNF capture
pAb tethered to the ELISA plate (#60238, Chemicon, Temecula, CA) at 4°C
overnight. Extracts were then removed and incubated in the presence or absence
of the biotinylated ELISA detection anti-BDNF mAb (1:200, #60583,
Chemicon, Temecula, CA) overnight at 4°C. The resultant antigen–antibody
complexes were immobilized on streptavidin gel (#23113, Pierce, Rockford, IL),
incubated for 4 h at 4°C, allowed to settle and washed in homogenization buffer
(repeated 4×, 4°C). Complexes were eluted with sample buffer (32 mM Tris, pH
6.8, 13% v/v glycerol, 1% SDS, and 0.005% bromphenol Blue), run on 15%
PAGE/SDS gels (120 V, 2 h), and transferred to nitrocellulose membranes (Bio-
Rad, Hercules, CA). Membranes were blocked in PBS containing 0.1% Tween
and 5% (w/v) dried milk powder, probed overnight at 4°C with function-
blocking anti-BDNF mAb (1:1000, Clone 35928.11, #GF35L, EMD Bios-
ciences, San Diego, CA) in block buffer, and incubated for 1 h at 21°C in HRP-
conjugated anti-mouse IgG (1:5000, Jackson Immunoresearch, West Grove, PA)
in PBS containing 0.1% Tween. Reactive bands were visualized using HRPchemiluminescence (Immuno-Star HRP, Bio-Rad) on autoradiography film
(Super RX, Fuji Photo Film, Tokyo, Japan).
Statistics
All parameter values are expressed as mean ± SEM (or SD where noted).
Statistical significance was set at P b 0.05 and determined by unpaired, two-
tailed t test when comparing two datasets or by one-way ANOVA combined
with Bonferroni post-hoc multiple comparison testing for three or more datasets
using Prism 4.0 (GraphPad Software, San Diego, CA).Results and discussion
BDNF is expressed throughout CG development
BDNF was detected in embryonic ciliary ganglion extracts,
as well as in CG culture extracts, and culture media using a
sandwich ELISA kit (Chemicon, see Methods), as previously
described (Zhou et al., 2004). While the polyclonal capture and
monoclonal detection antibodies in the kit, as well as the
function-blocking anti-BNDF mAb (EMD Biosciences, used
below), were raised against human BDNF, they recognized
chicken BDNF in immunoprecipitation and immunodepletion
assays. First, as expected for recognizing BDNF homodimer, the
ELISA detection anti-BNDF mAb specifically immunoprecipi-
tated a 27 kDa protein from chicken brain homogenates probed
with the function-blocking anti-BNDF mAb (Fig. 1A, lanes 1,
2). Second, after incubation with polyclonal anti-BDNF capture
antibody tethered to the ELISA plate, chicken brain extracts
subjected to immunoprecipitation and probing as above were
depleted of 27 kDa protein (Fig. 1A, lanes 3, 4). The ELISA
detected BDNF in chicken CG extracts isolated during the E8–
E17 developmental period at levels (in pg/mg ganglionic wet
weight) that declined about 50% from E8 to E14 and remained
stable thereafter (Fig. 1B). Since 50% of CG neurons normally
die between E8 and E14 due to programmed cell death
(Landmesser and Pilar, 1974a), it can be inferred that endo-
genous BDNF remains constant on a per neuron basis
throughout development, thereby making it available to
exert a sustained influence in vivo. We recently found that
BDNF is present in E14 iris, the normal striated muscle target
of ciliary neurons in vivo, and that BDNF mRNA is present in
both E8 and E14 CG as well as in CG neuron cultures (Zhou
et al., 2004). Since BDNF endogenous to spinal cord ventral
horn is attributable to both retrograde transport to motor
neurons from striated muscle and local synthesis (Koliastsos et
al., 1993), a similar arrangement may apply for the CG. In the
absence of additional information, local BDNF synthesis in
the CG could be attributable to neurons and/or non-neuronal
support cells. Thus, the developmental reduction in absolute
levels of endogenous BDNF could reflect a balance between
altered synthesis within and retrograde transport from the iris,
in combination with changes in local ganglionic synthesis and
release.
Depolarizing activity increases BDNF expression and release
Since BDNF mRNA and protein levels are increased by
depolarization and subsequent Ca2+ elevation in neurons that
Fig. 2. Chronic depolarization increases levels of BDNF mRNA and protein in
CG neuron cultures. (A) Levels of BDNF mRNA (relative to GAPDH) were
assessed using real-time RT-PCR in CG neuron cultures grown for 3–4 days in
normal (5 mM KCl) MEMhs/eye without additional supplements (None, black
bar) or in MEMhs/eye containing 25 mM KCl (KCl, gray bar) or 20 μM nicotine
(Nicotine, striped bar). Asterisks indicate significantly higher levels of BDNF
mRNA expression (P b 0.05) in cultures maintained in 25 mM KCl (n = 3
cultures) or 20 μM nicotine (n = 4) compared to companion control cultures
assayed in parallel. (B) Levels of BDNF protein (pg/ml) were determined by
ELISA from 3 to 4 days CG culture extracts (Cells) and culture media (Media).
Levels were compared for cultures grown in normal MEMhs/eye without
additional supplements (None, black bar) and in MEMhs/eye containing 25 mM
KCl (KCl, gray bars). Asterisks indicate significantly higher levels of BDNF-
like protein (P b 0.05) in cell extracts or released into the media when cultures
(n = 2 for both) were maintained in 25 mM KCl, as compared to controls.
Fig. 1. BDNF is expressed throughout CG development. (A) Commercially
available antibodies raised against human BDNF also recognize chicken BDNF.
E14 chicken brain extracts immunoprecipitated with the ELISA anti-BDNF
detection mAb (IP, #60583, Chemicon) were analyzed on blots probed with the
anti-BDNF blocking mAb (Probe, Clone 35928.11, #GF35L, EMD Bios-
ciences) which recognized a 27 kDa protein consistent with BDNF homodimer
(lane 1). The 27 kDa protein was depleted in chicken brain extracts that were
first incubated with anti-BDNF pAb tethered to the ELISA plate (ELISA
depletion) (lane 3). In the absence of anti-BDNF detection mAb, sham
immunoprecipitations yielded little to no 27 kDa signal without (lane 2) or with
(lane 4) prior ELISA depletion. (B) Levels of BDNF-like protein in CG were
determined at the indicated embryonic ages (NT, not tested). Results are
expressed as picograms BDNF per milligram ganglion wet weight (gray bars,
mean ± SD) based on duplicate ELISA measurements from 13 to 18 ganglia for
each day. The accompanying data points and connecting line indicate the
average number of neurons per CG at each indicated day expressed as a percent
of the ≈6300 determined at E8 (adapted from Landmesser and Pilar, 1974a).
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et al., 1990), we reasoned that endogenous BDNF might display
a similar activity dependence in CG neurons. This possibility
was tested by chronically exposing CG neurons to elevated KCl
concentrations in cell culture as a means of providing
depolarization to approximate sustained activity (Fig. 2). It
was previously shown that elevated KCl concentrations
depolarize CG neurons and when continuously elevated trigger
sufficient voltage-dependent influx of Ca2+ through VDCCs to
support CG neuronal survival (Collins and Lile, 1989; Collins et
al., 1991). When CG neurons were grown for 3–4 days in
MEMhs/eye containing 25 mM KCl, BDNF mRNA levels
assessed by real-time RT-PCR were 23.4-fold higher than in
parallel control cultures grown in normal MEMhs/eye (n = 3 test
and control cultures, P b 0.05) (Fig. 2A). Shorter exposure
times appeared less effective; in two experiments, growing
cultures MEMhs/eye containing 25 mM KCl overnight increased
levels of BDNF mRNA by 8.3-fold compared to controlsmaintained in normal MEMhs/eye when both were tested on day
4 (D4, data not shown). Supplementing MEMhs/eye with 20 μM
nicotine for 3–4 days, to chronically activate nAChRs
(McNerney et al., 2000; Nai et al., 2003) and depolarize CG
neurons, also significantly increased BDNF mRNA levels. We
previously found that nicotine-induced nAChR-dependent
depolarization supports CG neuronal survival via VDCC
activation, and Ca2+ influx, similar to that for KCl (Pugh and
Margiotta, 2000). Nicotine enhanced BDNF mRNA to a much
smaller extent (1.5-fold, n = 4, P b 0.05) than did KCl, however,
presumably because nAChRs desensitize (Quick and Lester,
2002), thereby limiting the amount of sustained depolarization
and subsequent elevation of intracellular Ca2+.
In accord with the upregulation in BDNF mRNA, levels of
BDNF protein determined by ELISA also increased dramati-
cally in response to KCl depolarization (Fig. 2B). In cell
extracts from two cultures grown in MEMhs/eye containing 25
mM KCl, BDNF levels were 419 ± 3 pg/ml (mean ± SD)
compared with nearly undetectable amounts (8 ± 3 pg/ml) seen
in control cultures maintained in normal MEMhs/eye (P b 0.05).
As in other systems (Ghosh et al., 1994; Goodman et al., 1996;
Zafra et al., 1990), activity-dependent BDNF release was also
demonstrable in CG cultures, with high levels of BDNF-like
protein appearing in 25 mMKCl culture media (200 ± 64 pg/ml,
n = 2) compared with nearly undetectable levels for control
cultures maintained in normal MEMhs/eye. These findings
Fig. 3. Canonical BDNF signaling supports CG neuronal survival. (A) The mean
percent survival of E8 CG neurons relative to that on D0 is plotted from D0 to
D4 (E8–E12 equivalent) for cultures maintained in various culture media. The
culture media were MEMhs without added supplements (None, open squares),
and MEMhs supplemented with 3% (v/v) eye extract (Eye, filled squares), or 5
ng/ml BDNF (BDNF5, filled circles), or 50 ng/ml BDNF (BDNF50, open
circles). Results depicted were obtained from 5 to 9 fields per well in 2–4
experiments. Error bars represent ± SEM (smaller than the symbol size for “Eye”
and “None” conditions at D4). Asterisks in this and subsequent figures depict
significantly higher survival for the indicated conditions relative to MEMhs
alone (here, P b 0.001 for each). Note that the trophic effects of BDNF appear as
early as D1 and are consistently greater for the lower BDNF concentration (5 ng/
ml) from D1 to D4. (B) TrkB and MAPK dependence of BDNF-supported
survival. Data in (B) are D4 results taken from the complete time course depicted
in panel A. Top. High BDNF concentration activates p75NTR attenuating the
trophic effects of TrkB activation. D4 survival in MEMhs supplemented with 3%
eye extract (Eye, black bar), with BDNF at high or low concentration (BDNF5,
BDNF50, gray bars), or with BDNF and an antibody (anti-CHEX, 1:100) that
selectively binds p75NTR and blocks its function (BDNF5 + αCHEX,
BDNF50 + αCHEX, white bars), is shown. Note that by blocking p75NTR anti-
CHEX unmasks significant survival in 50 ng/ml BDNF, indistinguishable from
that seen in 5 ng/ml BDNF without or with anti-CHEX (P N 0.05 for each). (B)
Bottom. MAPK activation is required for BDNF-supported survival. D4 survival
in MEMhs supplemented with 5 ng/ml BDNF (gray bar) is reduced by
coincubation with PD98059 (7 μM, white bar) to block MEK (P b 0.001), a
level not significantly different from that seen for MEMhs alone (P N 0.05, not
shown). D4 survival for neurons maintained in MEMhs (34.1 ± 1.9%, n = 42) was
higher in this series of experiments than seen subsequently (i.e. Figs. 4 and 5).
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expression of BDNF mRNA and protein in CG neurons and are
consistent with the somewhat smaller 5- to 10- fold increases in
BDNF expression seen for hippocampal neurons following
shorter depolarization treatment (Goodman et al., 1996; Zafra et
al., 1990). As concluded previously for cortical neurons (Ghosh
et al., 1994), depolarization may upregulate BDNF transcription
and release from CG neurons themselves or from adjacent non-
neuronal cells present in the cultures. Consistent with the former
(autocrine) model, other studies have demonstrated that
activity- and Ca2+-dependent mechanisms activate transcription
factors (e.g. CREB, c-fos) in CG neurons (Chang and Berg,
2001). These or other activity-dependent transcription factors
could underlie the upregulation of BDNF induced by chronic
KCl or nicotine exposure, as seen here. Regardless of its source,
release of endogenous BDNF would be expected to activate
functional TrkB receptors on CG neurons and thereby trigger
intracellular signals relevant to regulating nicotinic receptors,
synaptic function (Zhou et al., 2004), and possibly survival.
Depolarization-induced survival of CG neurons is partially
BDNF-dependent
KCl depolarization provides significant trophic support to
CG neurons in culture. In MEMhs (i.e. without eye extract or
other supplements), usually only 10–20% of CG neurons
survive for 7 days, whereas in MEMhs containing elevated (25
mM) KCl, 70–100% of the neurons will survive (Nishi and
Berg, 1981; Pugh and Margiotta, 2000; Scott and Fisher, 1970).
Since KCl depolarization greatly increased BDNF expression
and release in CG cultures, a causal connection with
depolarization-enhanced survival was considered. Such a
connection predicts that exogenous BDNF will support CG
neuronal survival in culture, an expectation seemingly at odds
with previous findings (Lindsay et al., 1985). We therefore re-
examined the ability of BDNF to support the survival of CG
neurons and found it does so when tested under appropriate
low concentration conditions (Fig. 3). Specifically, a 5 ng/ml
BDNF concentration supported ≈80% survival of CG neurons
on D4, a level significantly different from that seen in MEMhs
(P b 0.001) and approaching that seen in MEMhs containing
3% eye extract (Eye, Figs. 3A, B). The apparent N100% D4
neuronal survival seen in MEMhs/eye on some days in this and
subsequent experiments is unlikely to result from neurogen-
esis. Using BrdU as a marker for dividing cells, we found that
only 1.0 ± 0.9% of CG neuronal nuclei score as BrdU positive
(n = 6) during the first 3 days in MEMhs/eye (Pugh and
Margiotta, unpublished results). A more likely explanation
than neurogenesis is that some neurons have ill-defined
characteristics on D0 but eventually acquire more definitive
neuronal morphology and are counted as living neurons on
subsequent days. Interestingly, a 10-fold higher BDNF
concentration (50 ng/ml, BDNF50), identical to that used
previously (Lindsay et al., 1985), failed to significantly
increase neuronal survival above that seen in MEMhs
(P N 0.05, Figs. 3A, B).
Since high-affinity (TrkB) and low-affinity (p75NTR)
BDNF receptors (linked to neuronal survival and death,
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present on CG neurons (Yamashita et al., 1999; Zhou et al.,
2004) (Q Nai, XD Zhou, and JF Margiotta, unpublished
results), we reasoned that the reduced trophic efficacy of
BDNF applied at 50 ng/ml relative to 5 ng/ml might result
from opposing consequences of TrkB and p75NTR receptor
activation. To test this idea, we utilized an antiserum that
binds p75NTR receptors and blocks their function (anti-
CHEX) (Weskamp and Reichardt, 1991). Indeed, in the
presence of anti-CHEX, 50 ng/ml BDNF supported ≈90% D4
CG neuronal survival, a level indistinguishable from that
attained using 5 ng/ml BDNF applied with or without anti-
CHEX (85% and 80%, respectively, P N 0.05, Fig. 3B, top).
We conclude that 5 ng/ml BDNF (2 × 10−10 M) supports CG
neuronal survival because this concentration preferentially
activates high-affinity TrkB receptors (KD ≈ 10−11 M), whereas
at 50 ng/ml (2 × 10−9 M), BDNF has no net effect (Lindsay et
al., 1985) because, in addition to TrkB, the higher concentrationalso activates low-affinity p75NTR receptors (KD ≈ 10−9 M)
linked to cell death (Dechant et al., 1993; Freidin, 2001; Huang
and Reichardt, 2001; Rodriguez-Tebar and Barde, 1988). In
other systems, NTs activate MAPK to preserve neuronal survival
(Becker et al., 1998; Bonni et al., 1999; Hetman et al., 1999).
Consistent with these findings, BDNF-mediated survival of CG
neurons depended on the MAPK signaling pathway since its
inhibition with the MAPK kinase (MEK1) inhibitor PD98059
(Hansen et al., 2001) (7 μM) blocked the ability of BDNF (5
ng/ml) to promote neuronal survival (Fig. 3B, bottom). In
separate experiments, 7 μM PD98059 did not alter D4 survival
of CG neurons maintained in MEMhs (P N 0.10, n = 8) or
MEMhs/eye (P N 0.05, n = 4). Thus, exogenous BDNF is capable
of supporting CG neuronal survival in a manner consistent with
utilization of a canonical TrkB-mediated, MAPK-dependent
signaling pathway.
Since a low concentration of exogenous BDNF supported
CG neuronal survival, we next tested whether BDNF released
by KCl depolarization contributes to survival supported by this
growth condition. To do so, a function-blocking anti-BNDF
mAb (anti-BDNF, 10 μg/ml) that binds to free BDNF,
neutralizes the function of endogenous BDNF in culture
(unpublished data from EMD Biosciences, Inc., San Diego,
CA), and recognizes chicken BDNF (Fig. 1A) was tested for its
ability to limit the trophic effect of 15 mM KCl, a submaximal
concentration for promoting survival (EC50 = 13 mM, PC Pugh
and JF Margiotta, unpublished) (Fig. 4A). From D1 to D4 in
culture, CG neurons grown in MEMhs containing 15 mM KCl
maintained a relatively constant ≈70% level of neuronal
survival that was significantly higher on D4 (72 ± 4%, n = 4)Fig. 4. BDNF contributes to KCl-supported survival of CG neurons in culture.
(A) The mean percent survival of E8 CG neurons is plotted as in Fig. 3A.
MEMhs (containing 5 mM KCl) was supplemented with 3% eye extract (Eye),
10 mM KCl (KCl, 15 mM final concentration), 10 mM KCl + 10 μg/ml anti-
BDNF (KCl + αBDNF), or not supplemented (None), as indicated. Error bars
represent SEM (smaller than the symbol size for KCl + anti-BDNF condition).
The dagger (†) indicates that D4 survival for MEMhs supplemented with KCl
was significantly reduced by the inclusion of anti-BDNF. Results depicted were
obtained from 9 to 12 fields per well in 4 experiments. (B and C) MAPK and
CaMKII activations are required for full KCl-supported survival. For simplicity,
bar graphs depict percent survival only at D4. (B) E8 CG neurons were grown in
MEMhs supplemented with 3% eye extract (Eye, black bar), 10 mM KCl (KCl,
gray bar), 10 mM KCl + 7 μM PD98059 (KCl + PD, white striped gray bar), or
MEMhs alone (None, white bar). The dagger indicates that inclusion of PD98059
significantly reduces KCl supported survival. (C) Supplements to MEMhs were
as in B for “Eye”, “KCl”, and “None” conditions but also included 10 mM
KCl + 10 μM KN-93 (KCl + KN, black striped gray bar), 10 mM KCl + 10 μM
KN-93 + 10 μg/ml anti-BDNF (KCl + KN + αBDNF, black crossed gray bar),
and 10 mM KCl + 10 μM KN-93 + 7 μM PD98059 (KCl + KN + PD, white
crossed gray bar). Top dagger indicates that inclusion of KN-93 significantly
reduces KCl supported survival at D4 (P b 0.001). Note that combination of KN-
93 and anti-BDNF abolishes the trophic effect of KCl relative to MEMhs alone
(P N 0.05). Lower daggers indicate that combining KN-93 with PD98059
significantly reduces KCl-supported survival (right, P b 0.001) and does so
further than combining KN-93 with KCl (left, P b 0.05). The small apparent
differences in D4 survival for growth in supplemented MEMhs containing 15
mM KCl or 3% eye extract seen in panels A–C were not statistically significant
(P N 0.05 for all). Moreover, none of the respective D4 survival values obtained
in KCl or Eye conditions differed detectably between experiments depicted in
Figs. 3–5 (P N 0.05 for all).
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alone (20 ± 3%, P b 0.001). In the same series of
experiments, KCl and anti-BDNF were coapplied from D1
to D4 in culture. Under these conditions, long-term survival
decreased, paralleling that seen in MEMhs and reaching
52 ± 2% (n = 4) on D4, significantly lower than that for
neurons grown in MEMhs containing 15 mM KCl (P b 0.01)
but greater than that achieved in MEMhs alone (P b 0.001).
The anti-BDNF mAb treatment effects were specific since
non-immune mouse serum (1:800, expected to contain 10–20
μg/ml IgG, Harlowe and Lane, 1988) failed to detectably alter
neuronal survival supported by 15 mM KCl on D4 (P N 0.05,
n = 4). Moreover, in separate control experiments (data not
shown), anti-BDNF significantly reduced survival support
provided by 5 ng/ml exogenous BDNF (P b 0.05) to levels
that were indistinguishable from those seen in MEMhs
(P N 0.05, n = 2). While different culture conditions were
used to induce BDNF release than in the survival assays, the
BDNF level released by KCl depolarization (Fig. 2) is about
0.5 ng/ml or 2 × 10−11 M. Although local relevant availability
may be higher, this concentration is sufficient for high-affinity
BDNF binding to TrkB on chicken neurons (KD ≈ 10−11 M)
(Dechant et al., 1993; Rodriguez-Tebar and Barde, 1988).
These results therefore suggest that survival support provided
by membrane depolarization is partially attributable to the
stimulation of BDNF release from the CG cultures and
subsequent activation of TrkB-mediated signaling.
Depolarization induces survival via MAPK and CaMKII
Previous studies identify MAPK-dependent processes in
sequential calcium signaling in the nervous system (Rosen et
al., 1994). It is also known that NT activation of MAPK
protects neurons from death in various systems (Becker et al.,
1998; Bonni et al., 1999; Hetman et al., 1999), including CG
neurons (Fig. 3B). Since MAPK would be activated by either
KCl-induced membrane depolarization (Rosen et al., 1994) or
by the accompanying release of BDNF and TrkB activation,
we tested its contribution to KCl-induced CG neuron survival
using PD98059 to block MEK1-MAPK signaling (Fig. 4B).
Growth in MEMhs containing 15 mM KCl and PD98059 (7
μM) resulted in 46 ± 4% (n = 6) survival on D4, a
significantly lower level than that for parallel cultures grown
in MEMhs containing 15 mM KCl (75 ± 4, n = 6, P b 0.001)
but higher than that attained in parallel cultures maintained in
MEMhs alone (18 ± 1%, n = 6, P b 0.001). The lowered KCl-
supported D4 survival seen with MEK1 inhibitor was
indistinguishable from that seen with anti-BDNF (Fig. 4A),
suggesting that any direct contribution of chronic depolariza-
tion to MAPK activation (Rosen et al., 1994) is negligible for
CG neurons. Taken together, these results indicate that full
KCl-supported survival of CG neurons requires activation of
MAPK and suggest that increased BDNF release supports
survival by TrkB signaling mediated via MEK1 and MAPK
effectors.
The residual KCl-supported survival observed in anti-BDNF
and MEK1 inhibitor (Figs. 4A and B) experiments suggests that
a second pathway activated by membrane depolarizationsupports survival in parallel with BDNF/TrkB signaling. We
speculated that CaMKII, an effector activated by VDCC-
mediated Ca2+ influx, might also influence the KCl-supported
survival of CG neurons, as it does in other systems (Hanson and
Schulman, 1992). CaMKII is coupled to changes in gene
expression since blocking the enzyme abolishes activation of
the transcription factor CREB in CG neurons following
depolarization, thereby implicating interruption of CREB-
mediated gene regulation (Chang and Berg, 2001) known to
have significant effects on neuronal survival (Bito and
Takemoto, 2003). We therefore employed the CaMKII inhibitor
KN-93 (Sumi et al., 1991) to determine if CaMKII, like MAPK,
is required to support KCl-induced long-term CG neuron
survival (Fig. 4C). As with PD98059, inclusion of 10 μM KN-
93 alone did not detectably alter D4 survival in MEMhs or
MEMhs/eye (P N 0.05 and n = 4 for both, data not shown).
Application of 10 μMKN-93 in MEMhs containing 15 mMKCl
resulted in significantly reduced D4 neuronal survival (43 ± 2%)
compared to that for cultures grown in MEMhs containing 15
mM KCl alone (80 ± 3%, P b 0.001, n = 6 and 7, respectively),
however, indicating that CaMKII activity is required for full
KCl-induced survival support. Interestingly, inclusion of both
KN-93 and anti-BDNF in MEMhs containing 15 mM KCl
abolished the trophic effect of KCl depolarization, resulting in
D4 survival levels (13 ± 2%, n = 3, P b 0.001) that were
indistinguishable from that for neurons grown in MEMhs alone
(20 ± 2%, n = 7, P N 0.05). A similar result was obtained by
combining KN-93 with MEK1 inhibitor (PD98059) to block
both CaMKII and MAPK signaling; such treatment decreased
D4 KCl-stimulated survival to 30 ± 2% (n = 6), a level
significantly less than that obtained for MEMhs containing KCl
(P b 0.001) or KCl plus KN-93 (P b 0.05) and approaching that
seen for MEMhs. These findings indicate that full survival
induced by KCl depolarization requires parallel recruitment of
both BDNF-dependent (TrkB, MAPK) and -independent
(CaMKII) signaling pathways. Simple additivity of convergent
CaMKII and TrkB/MAPK pathways was not observed;
depolarization with 25 mM KCl failed to augment CG neuronal
survival supported by exogenous 5 ng/ml BDNF (data not
shown). In this case, we note that 5 ng/ml BDNF (2 × 10−10 M)
is 13-fold higher than the KD for binding to TrkB on chicken
neurons (≈1.5 × 10−11 M) (Dechant et al., 1993) and therefore
likely to be maximal for TrkB binding and subsequent MAPK
activation. Under such conditions, any augmentation of
survival due to activity-dependent increases in CaMKII
would presumably be offset by cell death brought about by
the accompanying upregulation of BDNF release activating
low-affinity p75NTR (KD ≈ 10−9 M). While these considera-
tions can explain the lack of survival additivity seen by
combining exogenous BDNF and KCl, levels of BDNF
produced by depolarization are expected to be quite low (Fig.
2) such that the contributions from MAPK and CaMKII
effectors would presumably be additive. Thus, these results
support a model where parasympathetic CG neuron survival
is influenced by activity impacting both CaMKII-dependent
and, via BDNF upregulation, TrkB/MAPK-dependent survival
pathways.
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At later stages of CG development (≥E14), ganglionic
synapses transmit reliably at high frequency (Chang and Berg,
1999; Landmesser and Pilar, 1972) and the effectiveness of
classic ganglionic growth factors (i.e. GDNF and CNTF)
plummets (Buj-Bello et al., 1995; Hashino et al., 2001). The
combined trophic influences of sustained synaptic activity and
available BDNF in vivo may therefore have particular
relevance for maintaining mature CG neurons. To test this
idea, we compared the ability of exogenous BDNF to support
long-term survival of E14 CG neurons in cell culture with that
of GDNF, CNTF, and eye extract (Fig. 5). As expected from
previous studies (Buj-Bello et al., 1995; Hashino et al., 2001),
GDNF (50 ng/ml), CNTF (7 ng/ml), and eye extract (3%, v/v)
all failed to support long-term neuronal survival of E14 CG
neurons. After 7 days in culture (E21 equivalent), the levels of
neuronal survival in MEMhs supplemented with GDNF, CNTF,
or eye extract were all similar (16–30%) and not significantly
different from the 29 ± 4% level achieved in MEMhs alone
(P N 0.05 for each). By contrast, BDNF (5 ng/ml) providedFig. 5. BDNF selectively supports the survival of mature CG neurons. (A) Seven
days survival time course for E14 CG neurons. Growth conditions depicted are
MEMhs alone (None, white boxes) or MEMhs supplemented with 3% (v/v) eye
extract (Eye, black boxes) or 5 ng/ml BDNF (BDNF, black circles). (B) Survival
summary for E14 neurons at D7 (E21 equivalent) maintained throughout in
MEMhs supplemented with eye extract (Eye, black bar), 5 ng/ml BDNF (BDNF,
gray bar), 50 ng/ml GDNF (GDNF, gray/white bar small checks), 7 ng/ml CNTF
(CNTF, gray/white bar large checks), or MEMhs alone (None, white bar).substantial trophic support to the neurons, promoting 51 ± 2%
survival on D7, a level significantly greater than that seen for
any other condition (P b 0.01, n = 4 for all). These results
support the hypothesis that the ability of BDNF to act
coordinately with activity in supporting CG neuron survival is
particularly relevant at late stages of embryonic development
when the neurons are active but no longer responsive to classic
ganglionic growth factors.
Conclusions
Our results elucidate an unanticipated relevance for BDNF
signaling in supporting long-term survival of parasympathetic
ciliary ganglion neurons. Endogenous BDNF is available
throughout CG development, and exogenous BDNF, acting
via high-affinity TrkB receptors and canonical MAPK-depen-
dent signal pathways, supports long-term survival of E8 CG
neurons in culture. In addition, the expression of BDNF in CG
neuron cultures is upregulated by depolarization, as seen in
other systems, such that endogenous BDNF contributes to
activity-supported survival. Lastly, unlike the classic CG
neurotrophic factors (CNTF and GDNF), which decline in
efficacy during development, BDNF remains capable of
promoting long-term survival of mature (E14) CG neurons
such that the coordinated effects of synaptic activity and
neurotrophic factors may have relevance in vivo.
It seems likely that other non-classical neurotrophic factors
acting via MAPK signaling also influence CG neuronal
survival and development. We recently found, for example,
that high-affinity receptors for NGF and NT3 (TrkA and
TrkC, respectively) are also expressed in CG homogenates
and on CG neurons, respectively, and that exogenous NGF
and NT3 support MAPK-dependent long-term survival of CG
neurons at levels similar to those seen in response to BDNF
(Pugh, Dittus and Margiotta, unpublished results). While the
localization and developmental expression patterns of NGF
and NT3 in the CG are unknown, it is possible that NGF and
NT3 generate signals that interact with those produced by
BDNF and/or activity to influence survival outcomes in CG
neurons. In addition, neuropeptides are also implicated in
promoting neuronal survival (Huang and Reichardt, 2003; Ip,
1998; Meriney et al., 1991; Vaudry et al., 2000). Recent
studies implicate one such neuropeptide, pituitary adenylate
cyclase activating polypeptide (PACAP). PACAP is present in
CG at levels that increase through development (Pugh and
Margiotta, in press), concentrated in presynaptic terminals
abutting on ciliary neurons, and released by KCl depolariza-
tion (Sumner et al., 2004). We previously found that PACAP
activates high-affinity (PAC1) receptors on CG neurons that
couple via G-proteins to activate both adenylate cyclase and
phospholipase-C-dependent effectors resulting in rapid, potent
nAChR modulation (Margiotta and Pardi, 1995; Pardi and
Margiotta, 1999) and more recently that it triggers prolonged
changes in gene expression (Sumner et al., 2004). Moreover,
exogenous PACAP supports long-term PAC1-dependent
survival of CG neurons (Pugh and Margiotta, 2000) and,
like BDNF, exerts activity-modulated trophic actions via
190 P.C. Pugh et al. / Developmental Biology 291 (2006) 182–191MAPK signaling (Pugh and Margiotta, in press). Thus, the
long-term survival of parasympathetic CG neurons is more
multidimensional than previously expected. While CNTF (and
its avian orthologue, GPA) and GDNF clearly provide trophic
support at early times, our results indicate that neurotrophins
such as BDNF and neuropeptides such as PACAP acting
coordinately with activity provide unanticipated MAPK-
dependent support that, for BDNF, may be particularly
relevant at later stages of embryogenesis.Acknowledgments
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